Co-overexpression of CDC27 and PD-L1 defines an ultra-high-risk subgroup of acute myeloid leukemia in an Egyptian cohort.

Badawy AZ, Elkholy ARS, Elkholy AM, Genena SER, Hebesh EH, El-Sheity HH

Open source

DOI
10.1080/15321819.2026.2709873
Published
2026 Aug 1
Container
Journal of immunoassay & immunochemistry
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/15321819.2026.2709873,
  title = {Co-overexpression of CDC27 and PD-L1 defines an ultra-high-risk subgroup of acute myeloid leukemia in an Egyptian cohort.},
  author = {Badawy AZ and Elkholy ARS and Elkholy AM and Genena SER and Hebesh EH and El-Sheity HH},
  year = {2026},
  journal = {Journal of immunoassay \& immunochemistry},
  doi = {10.1080/15321819.2026.2709873},
  url = {https://doi.org/10.1080/15321819.2026.2709873}
}

RIS

TY  - JOUR
TI  - Co-overexpression of CDC27 and PD-L1 defines an ultra-high-risk subgroup of acute myeloid leukemia in an Egyptian cohort.
AU  - Badawy AZ
AU  - Elkholy ARS
AU  - Elkholy AM
AU  - Genena SER
AU  - Hebesh EH
AU  - El-Sheity HH
PY  - 2026
JO  - Journal of immunoassay & immunochemistry
DO  - 10.1080/15321819.2026.2709873
UR  - https://doi.org/10.1080/15321819.2026.2709873
ER  - 

APA

AZ, B., ARS, E., AM, E., SER, G., EH, H., & HH, E. (2026). Co-overexpression of CDC27 and PD-L1 defines an ultra-high-risk subgroup of acute myeloid leukemia in an Egyptian cohort.. Journal of immunoassay & immunochemistry. https://doi.org/10.1080/15321819.2026.2709873

Source records